The percentage of drugs in clinical phase 2 trials that move on to the next phase of clinical testing is:
A) 25%
B) 33%
C) 46%
D) 78%
B) 33%
About 33% of drugs in clinical phase 2 trials move on to the next phase of
clinical testing. These trials use between several dozen and 300 volunteers that have the disease
or condition that the drug is being tested to treat. The drug is assumed not to have a therapeutic
effect until further testing occurs.
You might also like to view...
What is the MOST common mechanism involved with an elbow injury?
a. rapid contraction of the bicep b. hitting the steering wheel c. nursemaid's elbow d. fall on an outstretched arm
Asherman, Halo, and Bolin devices are commercially available devices to use for which injury?
A) Flail chest B) Open chest wound C) Commotio cordis D) Pneumothorax
The Doctrine of Professional Discretion applies to:
a. medical records. b. subpoena duces tecum. c. standards of care. d. insurance policies.
Stress testing is a diagnostic procedure done to determine the likelihood of
A) ventricular arrhythmias. B) myocardial ischemia. C) myocardial infarction. D) CAD.